Viewing Study NCT06851559


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2026-03-20 @ 3:53 AM
Study NCT ID: NCT06851559
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
Sponsor: Phathom Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Eosinophilic Esophagitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vonoprazan View
None Adults View